Clinical Trials Browser

Metrorrhagia, Endometrial Neoplasms

NCT07465822 2026-03-19

LC of V-NOTES

Active not recruiting

19 enrolled

Metrorrhagia, Myofibroma, Adenomyosis

NCT07397715 2026-02-12

MUSA3

Recruiting

1,000 enrolled

Gynecologic

Uterine Anomalies, Dysmenorrhea, Dyspareunia, Infertility, Menorrhagia, Metrorrhagia, Myoma, Abdominal Pain, Adenomyoma, Hemostatic Disorders, Adenomyosis

NCT07250178 2026-01-07

ONSD as an ICP Marker in vNOTES and TLH

Phase NA Completed

66 enrolled

Gynecologic

Metrorrhagia, Endometrial Neoplasms, Myofibroma

NCT05538689 2025-09-29

SOUL

Phase 4 Withdrawn

Leiomyoma, Menorrhagia, Metrorrhagia, Pelvic Pain

NCT06802198 2025-09-05

STORY

Phase NA Not yet recruiting

500 enrolled

Endometriosis, Leiomyoma, Metrorrhagia, Adenomyosis

NCT07074795 2025-07-20

Use of Nitrous Oxide During Office Hysteroscopy

Phase NA Active not recruiting

400 enrolled

Agnosia, Gynatresia, Leiomyoma, Metrorrhagia

NCT07072364 2025-07-18

Fibroid AUB

Phase NA Recruiting

154 enrolled

Gynecologic

Leiomyoma, Metrorrhagia, Uterine Hemorrhage

NCT06024109 2025-05-13

BARHYSTER

Recruiting

132 enrolled

Gynecologic

Uterine Cervical Neoplasms, Endometriosis, Fallopian Tube Neoplasms, Metrorrhagia, Ovarian Neoplasms, Uterine Neoplasms, Uterine Prolapse, Endometrial Neoplasms

Clinical Trials

DETECTR

LC of V-NOTES

MUSA3

ONSD as an ICP Marker in vNOTES and TLH

SOUL

STORY

Use of Nitrous Oxide During Office Hysteroscopy

Fibroid AUB

BARHYSTER